IL115022A - Pharmaceutical compositions for inhibiting endometrial cancer - Google Patents
Pharmaceutical compositions for inhibiting endometrial cancerInfo
- Publication number
- IL115022A IL115022A IL11502295A IL11502295A IL115022A IL 115022 A IL115022 A IL 115022A IL 11502295 A IL11502295 A IL 11502295A IL 11502295 A IL11502295 A IL 11502295A IL 115022 A IL115022 A IL 115022A
- Authority
- IL
- Israel
- Prior art keywords
- pharmaceutical compositions
- endometrial cancer
- inhibiting endometrial
- inhibiting
- cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29385394A | 1994-08-22 | 1994-08-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL115022A0 IL115022A0 (en) | 1998-06-15 |
| IL115022A true IL115022A (en) | 2000-07-31 |
Family
ID=23130867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11502295A IL115022A (en) | 1994-08-22 | 1995-08-21 | Pharmaceutical compositions for inhibiting endometrial cancer |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0777476A4 (ja) |
| JP (1) | JPH10504824A (ja) |
| KR (1) | KR970705387A (ja) |
| AU (1) | AU688112B2 (ja) |
| CA (1) | CA2198119A1 (ja) |
| CZ (1) | CZ51897A3 (ja) |
| FI (1) | FI970717A0 (ja) |
| HU (1) | HUT76890A (ja) |
| IL (1) | IL115022A (ja) |
| MX (1) | MX9701327A (ja) |
| MY (1) | MY113757A (ja) |
| NO (1) | NO970783D0 (ja) |
| NZ (1) | NZ292017A (ja) |
| RU (1) | RU2161964C2 (ja) |
| TW (1) | TW404834B (ja) |
| WO (1) | WO1996005833A1 (ja) |
| ZA (1) | ZA956994B (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5856340A (en) * | 1995-02-28 | 1999-01-05 | Eli Lilly And Company | Method of treating estrogen dependent cancers |
| US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| KR20160066490A (ko) * | 2014-12-02 | 2016-06-10 | 주식회사 씨앤드씨신약연구소 | 헤테로사이클 유도체 및 그의 용도 |
| CN115825414B (zh) * | 2023-01-09 | 2023-04-25 | 中国医学科学院北京协和医院 | 血液或尿液代谢标志物及其在子宫内膜癌早筛中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
| US5482949A (en) * | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
| AU6556194A (en) * | 1993-04-07 | 1994-10-24 | Ligand Pharmaceuticals Incorporated | Method for screening for receptor agonists |
| DK0652004T3 (da) * | 1993-10-15 | 2002-09-02 | Lilly Co Eli | Fremgangsmåder til behandling af resistente neoplasmer |
| CZ52297A3 (en) * | 1994-08-22 | 1997-08-13 | Lilly Co Eli | Pharmaceutical preparation for inhibiting primary endometrial hyperplasia |
| US5843964A (en) * | 1994-09-22 | 1998-12-01 | Eli Lilly And Company | Methods of inhibiting endometrial mitoses |
-
1995
- 1995-08-21 CZ CZ97518A patent/CZ51897A3/cs unknown
- 1995-08-21 TW TW084108700A patent/TW404834B/zh not_active IP Right Cessation
- 1995-08-21 HU HU9701499A patent/HUT76890A/hu unknown
- 1995-08-21 ZA ZA9506994A patent/ZA956994B/xx unknown
- 1995-08-21 KR KR1019970701095A patent/KR970705387A/ko not_active Application Discontinuation
- 1995-08-21 IL IL11502295A patent/IL115022A/xx not_active IP Right Cessation
- 1995-08-21 CA CA002198119A patent/CA2198119A1/en not_active Abandoned
- 1995-08-21 EP EP95930243A patent/EP0777476A4/en not_active Withdrawn
- 1995-08-21 WO PCT/US1995/010651 patent/WO1996005833A1/en not_active Application Discontinuation
- 1995-08-21 RU RU97104160/14A patent/RU2161964C2/ru active
- 1995-08-21 MY MYPI95002449A patent/MY113757A/en unknown
- 1995-08-21 JP JP8508265A patent/JPH10504824A/ja active Pending
- 1995-08-21 NZ NZ292017A patent/NZ292017A/en unknown
- 1995-08-21 AU AU33700/95A patent/AU688112B2/en not_active Ceased
- 1995-08-21 MX MX9701327A patent/MX9701327A/es unknown
-
1997
- 1997-02-20 FI FI970717A patent/FI970717A0/fi unknown
- 1997-02-20 NO NO970783A patent/NO970783D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW404834B (en) | 2000-09-11 |
| IL115022A0 (en) | 1998-06-15 |
| MY113757A (en) | 2002-05-31 |
| KR970705387A (ko) | 1997-10-09 |
| AU688112B2 (en) | 1998-03-05 |
| WO1996005833A1 (en) | 1996-02-29 |
| AU3370095A (en) | 1996-03-14 |
| JPH10504824A (ja) | 1998-05-12 |
| CZ51897A3 (en) | 1997-06-11 |
| NO970783L (no) | 1997-02-20 |
| EP0777476A1 (en) | 1997-06-11 |
| CA2198119A1 (en) | 1996-02-29 |
| NZ292017A (en) | 2000-07-28 |
| FI970717A (fi) | 1997-02-20 |
| MX9701327A (es) | 1997-05-31 |
| ZA956994B (en) | 1997-02-21 |
| NO970783D0 (no) | 1997-02-20 |
| RU2161964C2 (ru) | 2001-01-20 |
| HUT76890A (en) | 1997-12-29 |
| EP0777476A4 (en) | 1999-06-23 |
| FI970717A0 (fi) | 1997-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA957247B (en) | Pharmaceutical compositions | |
| IL117237A0 (en) | Pharmaceutical composition for piperidinoalkanol compounds | |
| EG24118A (en) | Pharmaceutical compositions | |
| HUT74746A (en) | Pharmaceutical compositions containing p antagonist | |
| GB9616672D0 (en) | Pharmaceutical compositions | |
| IL113329A0 (en) | Benzamide-containing pharmaceutical compositions | |
| GB9418609D0 (en) | Pharmaceutical compositions | |
| GB9610359D0 (en) | Pharmaceutical compositions | |
| ZA9710919B (en) | Pharmaceutical compositions containing N-sulphony-lindole derivatives | |
| ZA954469B (en) | Pharmaceutical compositions | |
| GB9622681D0 (en) | Pharmaceutical compositions | |
| IL115022A (en) | Pharmaceutical compositions for inhibiting endometrial cancer | |
| GB9606429D0 (en) | Pharmaceutical compositions | |
| ZA959081B (en) | Pharmaceutical compositions | |
| GB9613457D0 (en) | Pharmaceutical compositions | |
| GB9406835D0 (en) | Pharmaceutical compositions | |
| GB2295825B (en) | Pharmaceutical compositions | |
| IL106763A0 (en) | Pharmaceutical compositions for treating cancer | |
| GB9618376D0 (en) | Pharmaceutical compositions | |
| GB9400047D0 (en) | Pharmaceutical compositions | |
| HU9400096D0 (en) | Pharmaceutical compositions | |
| GB9610136D0 (en) | Pharmaceutical compositions | |
| GB9707483D0 (en) | Pharmaceutical compositions | |
| GB9411933D0 (en) | Pharmaceutical compositions | |
| ZA954838B (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |